A 54-Year-Old Woman with ER+/PR+ Breast Cancer

EP. 1: Introduction: A 54-Year-Old Woman With ER+/PR+ Breast Cancer

February 4th 2022

Lowell Hart, MD, FACP, introduces our patient case, a 54-year-old woman with ER+/PR+ breast cancer, and discusses his strategy and the risk of recurrence for the disease.

EP. 2: Adjuvant Therapy Options for HR+ Breast Cancer

February 4th 2022

Dr Hart explains the different adjuvant therapy options for patients with HR+ breast cancer.

EP. 3: CDK4/6 Inhibitor Breast Cancer Clinical Trials

February 4th 2022

Dr Hart delves into the CDK4/6 inhibitor clinical trials for breast cancer, some that he’s even participated in.

EP. 4: Common Adverse Events With CDK4/6 Inhibitors

February 4th 2022

Lowell Hart, MD, FACP, lists the different types of adverse events that are common when CDK4/6 inhibitors are used in both the adjuvant and advanced cancer setting.

EP. 5: Case Patient Prognosis

February 4th 2022

Dr Hart explains his prognosis for our case patient.

EP. 6: ER+ Early Breast Cancer Future Directions and A Note on Ki-67 Analyses

February 4th 2022

Lowell Hart, MD, FACP, discusses what he’d like to see in the future for the treatment of ER+ breast cancer and includes a note concerning Ki-67 analyses.